Robert C Welliver, MD

Dr. Robert Welliver’s professional goals include understanding how patients become ill with respiratory syncytial virus and influenza virus, which are the most important respiratory pathogens of early life, and for which there is neither a satisfactory means of prevention nor an effective, specific form of treatment. Dr. Welliver is studying these infections using in vivo and ex vivo models; evaluating the role of lipoxins and leukotrienes in causing clinical illness. His larger goal is the development of vaccines and antiviral agents using in vivo models that develop disease closely resembling that seen in human infants.Dr. Robert Welliver’s professional goals include understanding how patients become ill with respiratory syncytial virus and influenza virus, which are the most important respiratory pathogens of early life, and for which there is neither a satisfactory means of prevention nor an effective, specific form of treatment. Dr. Welliver is studying these infections using in vivo and ex vivo models; evaluating the role of lipoxins and leukotrienes in causing clinical illness. His larger goal is the development of vaccines and antiviral agents using in vivo models that develop disease closely resembling that seen in human infants.

Position

Chief, Section of Infectious Diseases, Department of Pediatrics, College of Medicine, University of Oklahoma Health Sciences Center

Education

University of Florida College of Medicine

Fellowships

UCLA Medical Center

Residencies

UCLA Medical Center

Board Certifications

Pediatrics and Pediatric Infectious Diseases